EDGEMOND JAMES bought UTHR
May 21, 2026 · Form 4 insider transaction
EDGEMOND JAMES bought 10,000 shares of United Therapeutics Corporation at $117.76 per share, a transaction worth $1.18M. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
10,000
Price
$117.76
Total value
$1.18M
InsiderEDGEMOND JAMES
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMay 21, 2026
Filing dateMay 22, 2026
Shares owned after28,876
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025.